150 results
Page 7 of 8
8-K
EX-3.1
ehy2p4 qgpl85xb
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
10-K/A
3uaw6w4ebogxt 718mpa
7 Nov 14
Annual report (amended)
12:00am
DEF 14A
ultavp0m80tm
27 Oct 14
Definitive proxy
12:00am
PRER14A
kmydm5nwz40
23 Oct 14
Preliminary revised proxy
12:00am
8-K
EX-3.1
jtp14l9sujz
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
8-K
EX-10.1
af8ipueh
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
10-K
yjq otnw3dp3vjtbq1
29 Sep 14
Annual report
12:00am
8-K
EX-10.1
5usxegt
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
zyoyocn 8e6bag5
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
10-12G/A
EX-99.1
ck2wr mf8oy4xeb
6 Feb 14
Registration of securities (amended)
12:00am
8-K
EX-10.1
ywpdsw
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
v6pbb8c1d 8rwv5f3n
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
10-12G/A
EX-99.1
s5u0mz
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
96k8f ubw4nb7l2a2s
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.4
9p4ey3ifuf42kzpc an
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.5
qj0ulzs
21 Nov 13
Registration of securities (amended)
12:00am